Safety and efficacy of cognitive training plus epigallocatechin-3-gallate in young adults with Down's syndrome (TESDAD): a double-blind, randomised, placebo-controlled, phase 2 trial-Reference-Cited by-同舟云学术

Safety and efficacy of cognitive training plus epigallocatechin-3-gallate in young adults with Down's syndrome (TESDAD): a double-blind, randomised, placebo-controlled, phase 2 trial

Published:2016-07 Issue:8 Volume:15 Page:801-810
ISSN:1474-4422
Container-title:The Lancet Neurology
language:en
Short-container-title:The Lancet Neurology

Author:

de la Torre Rafael,de Sola Susana,Hernandez Gimena,Farré Magí,Pujol Jesus,Rodriguez Joan,Espadaler Josep María,Langohr Klaus,Cuenca-Royo Aida,Principe Alessandro,Xicota Laura,Janel Nathalie,Catuara-Solarz Silvina,Sanchez-Benavides Gonzalo,Bléhaut Henri,Dueñas-Espín Iván,del Hoyo Laura,Benejam Bessy,Blanco-Hinojo Laura,Videla Sebastiá,Fitó Montserrat,Delabar Jean Maurice,Dierssen Mara

Publisher

Elsevier BV

Subject

Neurology (clinical)

Reference30 articles.

1. Therapeutic approaches in the improvement of cognitive performance in Down syndrome: past, present, and future;de la Torre;Prog Brain Res,2012

2. Down syndrome: the brain in trisomic mode;Dierssen;Nat Rev Neurosci,2012

3. Individual and environmental characteristics associated with cognitive development in Down syndrome: a longitudinal study;Couzens;J Appl Res Intellect Disabil,2012

4. A longitudinal study of children with Down syndrome who experienced early intervention programming;Connolly;Phys Ther,1993

5. The mechanisms of action of flavonoids in the brain: direct versus indirect effects;Rendeiro;Neurochem Int,2015

Cited by 227 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A review on synthetic inhibitors of dual-specific tyrosine phosphorylation-regulated kinase 1A (DYRK1A) for the treatment of Alzheimer’s disease (AD);Bioorganic & Medicinal Chemistry;2024-09

2. Down syndrome and DYRK1A overexpression: relationships and future therapeutic directions;Frontiers in Molecular Neuroscience;2024-07-24

3. Microscale thermophoresis (MST) and spectral shift (SpS) in drug discovery;TrAC Trends in Analytical Chemistry;2024-07

4. Developmental associations between cognition and adaptive behavior in intellectual and developmental disability;Journal of Neurodevelopmental Disorders;2024-06-13

5. Discovery of a novel DYRK1A inhibitor with neuroprotective activity by virtual screening and in vitro biological evaluation;Molecular Diversity;2024-06-04